Population
107 Duchenne muscular dystrophy and Becker muscular dystrophy carriers and 117 normal female controls of…
Design
Cross-sectional
Authors
Loading...
X-inactivation testing in blood should not guide risk assessment in DMD carriers; leaves open tissue-specific predictors of muscular involvement.
Highly skewed X-chromosome pattern in blood is not sufficient to predict muscular weakness in young DMD carriers, as it does not correlate with serum CK levels.
Sumita et al. (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: